Prestige Consumer Healthcare Quarterly Income Statement
NYSE: PBHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Prestige Consumer Healthcare revenue and earnings
In the quarter ended Jun 30, 2026, Prestige Consumer Healthcare generated $265.7 million in revenue, up 6.5% from the same quarter a year earlier. Net income was $29.2 million (-38.5% year over year), for a net margin of 11.0% versus a median of 16.9% in the prior 5 quarters. Gross margin was 51.3% (down from 56.2%) and operating margin 19.8%.
Diluted earnings per share came in at $0.61, down from $0.95.
Summary generated from market data by MetaCap's automated system. Methodology
Prestige Consumer Healthcare income statement (quarterly)
| Quarter (USD) | Q1 20272026-06-30 | Q4 20262026-03-31 | Q3 20262025-12-31 | Q2 20262025-09-30 | Q1 20262025-06-30 | Q4 20252025-03-31 | Q3 20252024-12-31 | Q2 20252024-09-30 | Q1 20252024-06-30 | Q4 20242024-03-31 | Q3 20242023-12-31 | Q2 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 265.71M | 281.62M | 283.44M | 274.11M | 249.53M | 296.52M | 290.32M | 283.79M | 267.14M | 276.99M | 282.74M | 286.32M |
| Revenue growth (YoY) | +6.48% | -5.03% | -2.37% | -3.41% | -6.59% | +7.05% | +2.68% | -0.88% | -4.36% | -3.11% | +2.62% | -1.02% |
| Cost of Revenue | 129.52M | 135.32M | 126.08M | 122.53M | 109.20M | 126.51M | 129.27M | 126.40M | 121.12M | 125.17M | 124.80M | 126.30M |
| Gross Profit | 136.19M | 146.30M | 157.37M | 151.58M | 140.33M | 170.01M | 161.05M | 157.38M | 146.02M | 151.82M | 157.94M | 160.02M |
| Operating Expenses | 83.67M | 70.81M | 74.88M | 71.91M | 68.58M | 81.58M | 69.09M | 73.04M | 73.98M | 69.66M | 71.11M | 71.77M |
| Operating Income | 52.52M | 75.49M | 82.49M | 79.67M | 71.76M | 88.43M | 91.96M | 84.34M | 72.05M | 82.15M | 86.83M | 88.25M |
| Interest Expense | — | — | — | — | — | — | 11.46M | 12.28M | 13.14M | — | 16.57M | 17.61M |
| Other Income (Expense) | -34.00K | 708.00K | -10.01M | -501.00K | 224.00K | -3.71M | -353.00K | -395.00K | -496.00K | 429.00K | -682.00K | -229.00K |
| Income Tax | 9.36M | 10.84M | 15.12M | 26.92M | 14.31M | 23.83M | 19.12M | 17.29M | 9.35M | 17.86M | 16.53M | 16.86M |
| Net Income | 29.18M | 53.93M | 46.70M | 42.21M | 47.47M | 50.13M | 61.03M | 54.38M | 49.07M | 49.46M | 53.05M | 53.56M |
| Net Income growth (YoY) | -38.53% | +7.58% | -23.49% | -22.37% | -3.26% | +1.35% | +15.05% | +1.53% | -7.90% | — | +2.11% | +4.97% |
| EPS (Basic) | 0.61 | 1.13 | 0.98 | 0.86 | 0.96 | 1.01 | 1.23 | 1.10 | 0.98 | 0.99 | 1.07 | 1.08 |
| EPS (Diluted) | 0.61 | 1.13 | 0.97 | 0.86 | 0.95 | 1.00 | 1.22 | 1.09 | 0.98 | 0.98 | 1.06 | 1.07 |
| Shares Outstanding (Basic) | 47.46M | — | 47.88M | 49.02M | 49.48M | — | 49.60M | 49.65M | 49.89M | — | 49.74M | 49.69M |
| Shares Outstanding (Diluted) | 47.60M | — | 48.09M | 49.26M | 49.83M | — | 49.99M | 50.00M | 50.27M | — | 50.13M | 50.08M |
| EBITDA | 61.27M | 83.84M | 90.08M | 87.33M | 79.42M | 95.68M | 98.83M | 92.27M | 80.17M | 90.00M | 94.48M | 95.89M |
| Gross Margin | 51.25% | 51.95% | 55.52% | 55.30% | 56.24% | 57.34% | 55.47% | 55.46% | 54.66% | 54.81% | 55.86% | 55.89% |
| Operating Margin | 19.77% | 26.81% | 29.10% | 29.06% | 28.76% | 29.82% | 31.68% | 29.72% | 26.97% | 29.66% | 30.71% | 30.82% |
| Net Margin | 10.98% | 19.15% | 16.47% | 15.40% | 19.02% | 16.91% | 21.02% | 19.16% | 18.37% | 17.86% | 18.76% | 18.71% |
This table shows 12 quarterly periods of Prestige Consumer Healthcare's income statement, from Q1 2027 back to Q2 2024, across 18 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow PBH's reporting calendar. What is a income statement?